Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manon Launay

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|January 8, 2026
Bringing 5-FU monitoring home: microsampling as the potential next step beyond DPD deficiency screeningManon Launay, Antonin Schmitt, Joseph Ciccolini
Therapeutic Drug Monitoring|July 1, 2024
Continuous Versus Intermittent Administration of Meropenem in Critically Ill PatientsManon Launay, Sophie Perinel-Ragey, Guillaume Thiery
Therapeutic Drug Monitoring|July 1, 2024
Personalized Amoxicillin Therapy in a Critically Ill Patient Undergoing Renal Replacement Therapy: A Grand RoundPhilippine Garrigue, Margot Reber, Sophie Perinel-Ragey, et al.
Therapeutic Drug Monitoring|May 25, 2023
Therapeutic Drug Monitoring Consulting Cannot be Ruled out by Model-Informed Precision DosingManon Launay, Patricia Correia, Guillaume Thiery, et al.
Cancer Chemotherapy and Pharmacology|November 21, 2025
Assessing plastic waste associated with LC-MS/MS method validation proceduresRomain Beziat, Chan Laurent-Britel, Samuel Huguet, et al.
Therapeutic Drug Monitoring|January 13, 2022
Gentamicin Assay Considering Both Analytical and Clinical Guidelines: A Square Peg in a Round Hole-Letter to the EditorClémence Marin, Sabine Cohen, Bernadette Bargoin, et al.
Cancer Chemotherapy and Pharmacology|May 20, 2026
The hidden impact of renal impairment on ribociclib exposure and co-medications: a case reportManon Launay, Alicja Puszkiel, Thomas Genevee, et al.
Clinical Pharmacokinetics|January 24, 2021
Pharmacokinetic and Pharmacodynamic Optimization of Antibiotic Therapy in Cystic Fibrosis Patients: Current Evidences, Gaps in Knowledge and Future DirectionsSophie Magréault, Charlotte Roy, Manon Launay, et al.
BMC Pediatrics|December 6, 2020
Accidental apixaban intoxication in a 23-month-old child: a case reportManon Launay, Yara Nasser, Isabelle Maubert, et al.
Therapeutic Drug Monitoring|December 20, 2019
Delaying Centrifugation and Freezing by Adding a Dihydropyrimidine Dehydrogenase Inhibitor Such as Gimeracil to Blood Sample Is Not a Valid Option to Simplify the Preanalytic Step for the Screening of Dihydropyrimidine Dehydrogenase Deficiency Using UracilemiaManon Launay, Yara Nasser, Yannick Tholance, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Expert Opinion on Drug Metabolism & Toxicology|January 8, 2026
Bringing 5-FU monitoring home: microsampling as the potential next step beyond DPD deficiency screeningManon Launay, Antonin Schmitt, Joseph Ciccolini
Therapeutic Drug Monitoring|July 1, 2024
Continuous Versus Intermittent Administration of Meropenem in Critically Ill PatientsManon Launay, Sophie Perinel-Ragey, Guillaume Thiery
Therapeutic Drug Monitoring|July 1, 2024
Personalized Amoxicillin Therapy in a Critically Ill Patient Undergoing Renal Replacement Therapy: A Grand RoundPhilippine Garrigue, Margot Reber, Sophie Perinel-Ragey, et al.
Therapeutic Drug Monitoring|May 25, 2023
Therapeutic Drug Monitoring Consulting Cannot be Ruled out by Model-Informed Precision DosingManon Launay, Patricia Correia, Guillaume Thiery, et al.
Cancer Chemotherapy and Pharmacology|November 21, 2025
Assessing plastic waste associated with LC-MS/MS method validation proceduresRomain Beziat, Chan Laurent-Britel, Samuel Huguet, et al.
Therapeutic Drug Monitoring|January 13, 2022
Gentamicin Assay Considering Both Analytical and Clinical Guidelines: A Square Peg in a Round Hole-Letter to the EditorClémence Marin, Sabine Cohen, Bernadette Bargoin, et al.
Cancer Chemotherapy and Pharmacology|May 20, 2026
The hidden impact of renal impairment on ribociclib exposure and co-medications: a case reportManon Launay, Alicja Puszkiel, Thomas Genevee, et al.
Clinical Pharmacokinetics|January 24, 2021
Pharmacokinetic and Pharmacodynamic Optimization of Antibiotic Therapy in Cystic Fibrosis Patients: Current Evidences, Gaps in Knowledge and Future DirectionsSophie Magréault, Charlotte Roy, Manon Launay, et al.
BMC Pediatrics|December 6, 2020
Accidental apixaban intoxication in a 23-month-old child: a case reportManon Launay, Yara Nasser, Isabelle Maubert, et al.
Therapeutic Drug Monitoring|December 20, 2019
Delaying Centrifugation and Freezing by Adding a Dihydropyrimidine Dehydrogenase Inhibitor Such as Gimeracil to Blood Sample Is Not a Valid Option to Simplify the Preanalytic Step for the Screening of Dihydropyrimidine Dehydrogenase Deficiency Using UracilemiaManon Launay, Yara Nasser, Yannick Tholance, et al.
Pageof 5